Your browser doesn't support javascript.
loading
Application of the adverse outcome pathway to identify molecular changes in prenatal brain programming induced by IUGR: Discoveries after EGCG exposure.
Kühne, Britta Anna; Teixidó, Elisabet; Ettcheto, Miren; Puig, Teresa; Planas, Marta; Feliu, Lidia; Pla, Laura; Campuzano, Victoria; Gratacós, Eduard; Fritsche, Ellen; Illa, Miriam; Barenys, Marta.
Afiliação
  • Kühne BA; Grup de Recerca en Toxicologia (GRET) i INSA-UB, Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain; BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and
  • Teixidó E; Grup de Recerca en Toxicologia (GRET) i INSA-UB, Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain.
  • Ettcheto M; Institute of Neuroscience, University of Barcelona, Barcelona, Spain; Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Madrid, Spain.
  • Puig T; New Therapeutic Targets Laboratory (TargetsLab), Department of Medical Sciences, University of Girona, Girona Institute for Biomedical Research, 17003, Girona, Spain.
  • Planas M; LIPPSO, Department of Chemistry, University of Girona, 17003, Girona, Spain.
  • Feliu L; LIPPSO, Department of Chemistry, University of Girona, 17003, Girona, Spain.
  • Pla L; BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Center for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
  • Campuzano V; Department of Biomedical Sciences, University of Barcelona School of Medicine and Health Sciences and Center for Biomedical Research on Rare Diseases (CIBER-ER), 08036, Barcelona, Spain.
  • Gratacós E; BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Center for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
  • Fritsche E; IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
  • Illa M; BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Center for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
  • Barenys M; Grup de Recerca en Toxicologia (GRET) i INSA-UB, Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain. Electronic address: mbarenys@ub.edu.
Food Chem Toxicol ; 170: 113506, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36370916
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article